Global Evidence
for Health Technologies

About

Epilogix develops strategy and generates evidence to demonstrate the value of health technologies. Health technology companies receive industry-leading quality delivered by a flexible, globally-distributed team, and a pricing structure that represents substantial savings from services delivered by large Contract Research Organizations (CROs). Epilogix projects have led to four peer-reviewed journal articles and eight peer-reviewed conference posters since the company's founding in 2020.

Leadership

Epilogix was founded by Vernon F. Schabert, Ph.D., an internationally-recognized health economist and pharmacoepidemiologist. He has 28 years of industry experience, leading practices and teams at global health companies such as IQVIA, Certara, IBM Watson Health, and Evidera/PPD. 

He has led studies of clinical populations in 19 countries around the globe and has earned awards in Europe and the Americas for his innovative research designs and insights. As an expert on healthcare data and analytics for medical affairs, health economics, outcomes research, and business analytics, he leads a network of Epilogix Global Advisors to deliver high-quality services for your value and access needs. 

Offerings

Epilogix delivers maximum impact for your stakeholders through the following offerings and services:

Evidence Strategy

Evidence Generation

*With support from Epilogix Global Advisors

Recognition

Epilogix staff have received multiple awards and distinctions from industry stakeholders and scientific societies:

Contact

Epilogix has operations in:

Epilogix also partners with a network of Global Advisors in the Americas, Europe, and Asia.

Please address correspondence to:

Epilogix LLC

4938 Hampden Lane, Suite 152

Bethesda MD 20814 USA

+1 (301) 825 5331